Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Kelowna, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 August
Lexaria Bioscience Corp. has filed 1,092 SEC EDGAR filings since 01 Mar 2006

SEC filing history

Showing 376-400 of 968 matching filings.

Per page
25
Current page
16
8-K File 000-52138

FORM 8-K

Filing date
25 Jul 2019
Reporting date
23 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
11 Jul 2019
Reporting date
11 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
21 Jun 2019
Reporting date
20 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
06 Jun 2019
Reporting date
04 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-52138

DEF 14A

Filing date
22 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
21 May 2019
Reporting date
15 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231585

FORM S-8

Filing date
17 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
09 May 2019
Reporting date
29 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231117

FORM S-8

Filing date
30 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
25 Apr 2019
Reporting date
15 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
11 Apr 2019
Reporting date
05 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2019
Reporting date
05 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2019
Reporting date
05 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2019
Reporting date
05 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
21 Mar 2019
Reporting date
20 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-52138

CT ORDER filing

Filing date
12 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Feb 2019
Reporting date
20 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
28 Jan 2019
Reporting date
28 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
22 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
16 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
19 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52138

FORM 8-K

Filing date
11 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .